ADAG
Price
$1.55
Change
-$0.09 (-5.49%)
Updated
Apr 4, 02:23 PM (EDT)
Capitalization
77.26M
54 days until earnings call
CRDF
Price
$2.73
Change
-$0.14 (-4.88%)
Updated
Apr 4, 02:32 PM (EDT)
Capitalization
190.92M
27 days until earnings call
Ad is loading...

ADAG vs CRDF

Header iconADAG vs CRDF Comparison
Open Charts ADAG vs CRDFBanner chart's image
Adagene
Price$1.55
Change-$0.09 (-5.49%)
Volume$300
Capitalization77.26M
Cardiff Oncology
Price$2.73
Change-$0.14 (-4.88%)
Volume$3.95K
Capitalization190.92M
ADAG vs CRDF Comparison Chart
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. CRDF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and CRDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ADAG: $1.64 vs. CRDF: $2.87)
Brand notoriety: ADAG and CRDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 82% vs. CRDF: 100%
Market capitalization -- ADAG: $77.26M vs. CRDF: $190.92M
ADAG [@Biotechnology] is valued at $77.26M. CRDF’s [@Biotechnology] market capitalization is $190.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileCRDF’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • CRDF’s FA Score: 0 green, 5 red.
According to our system of comparison, CRDF is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 3 TA indicator(s) are bullish while CRDF’s TA Score has 4 bullish TA indicator(s).

  • ADAG’s TA Score: 3 bullish, 6 bearish.
  • CRDF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRDF is a better buy in the short-term than ADAG.

Price Growth

ADAG (@Biotechnology) experienced а -1.50% price change this week, while CRDF (@Biotechnology) price change was -16.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.30%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was -18.93%.

Reported Earning Dates

ADAG is expected to report earnings on May 28, 2025.

CRDF is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-11.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDF($191M) has a higher market cap than ADAG($77.3M). ADAG YTD gains are higher at: -17.588 vs. CRDF (-33.871). ADAG has higher annual earnings (EBITDA): -31.51M vs. CRDF (-48.25M). ADAG (95.7M) and CRDF (91.7M) have equal amount of cash in the bank . CRDF has less debt than ADAG: CRDF (1.52M) vs ADAG (20.8M). ADAG has higher revenues than CRDF: ADAG (816K) vs CRDF (683K).
ADAGCRDFADAG / CRDF
Capitalization77.3M191M40%
EBITDA-31.51M-48.25M65%
Gain YTD-17.588-33.87152%
P/E RatioN/AN/A-
Revenue816K683K119%
Total Cash95.7M91.7M104%
Total Debt20.8M1.52M1,366%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGCRDF
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QASGX23.60N/A
N/A
Federated Hermes MDT Small Cap Growth A
GGLCX10.94N/A
N/A
Gabelli International Small Cap C
BAUAX26.94N/A
N/A
Brown Advisory Small-Cap Fdmtl Val Adv
JBGCX47.71N/A
N/A
JHancock Blue Chip Growth C
TSAGX51.35N/A
N/A
Touchstone Large Company Growth A

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and IBO have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and IBO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
N/A
IBO - ADAG
25%
Poorly correlated
-18.60%
ENTA - ADAG
25%
Poorly correlated
-4.72%
CRDF - ADAG
24%
Poorly correlated
-4.65%
NAMS - ADAG
23%
Poorly correlated
-1.15%
TIL - ADAG
22%
Poorly correlated
-9.22%
More

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-4.65%
MDGL - CRDF
46%
Loosely correlated
-2.24%
CMRX - CRDF
44%
Loosely correlated
+0.12%
ORMP - CRDF
39%
Loosely correlated
-1.82%
MRVI - CRDF
38%
Loosely correlated
-4.98%
QURE - CRDF
35%
Loosely correlated
-8.19%
More